ArticleInfluenza and other respiratory viruses2024

Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV-Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.